Researchers score $6M for technology that helps children with asthma

The four-year grant is part of a national $144 million initiative called Pediatric Research using Integrated Sensor Monitoring Systems or PRISMS.
Cohero Health

Cohero Health gets $2M for its respiratory disease management platform

The company's connected devices and mobile apps engage and empower respiratory patients by measuring lung function and tracking adherence.
Cohero Health smart inhalers

Cohero Health, ProCare Rx announce respiratory disease management partnership

The two companies have created the platform that combines adherence and lung function measurement with medication management services.
Wizdy Pets

Wizdy Pets games teaches kids about asthma

In the game, kids care for their pet's asthma, while learning about inhaler technique and timing, trigger identification and avoidance.
Propeller Health

Propeller, Aptar partner to develop connected metered dose inhaler

The sensor-laden device with a novel electronic dose counter is currently available for licensing and is expected to enter clinical studies later this year.
smart inhalers

Adherium smart inhalers to be used in a multi-country study

Researchers plan to recruit 675 adults to investigate the safety and efficacy of three different treatment regimens for mild asthma.
Propeller Health

Propeller Health, Boehringer Ingelheim team-up to improve for asthma and COPD patients

Patients will have the opportunity to enroll in a new program to determine how Propeller's hi-tech tool can impact adherence rates and patient engagement.

Cohero Health and Presspart Group launch a connected metered dose inhaler

The device's built-in sensors track the date and time when medication is actuated, which is then stored in onboard memory, and shared via Bluetooth.
Doctor On Demand

Doctor On Demand to make treating asthma and allergies easier for users

Together with Allergy & Asthma Network, the company will develop a series of services for people with asthma and allergies.

ResApp raises $12.5M for its mobile-enabled respiratory disease tool

The funds will be used to expedite an FDA approval for the adult diagnostic test, expand into in-clinic use, and enter European and Asian markets.